K. S. Hirsch

发表

Telomerase, cell immortality, and cancer.

C. Harley, J. Shay, H. Hirte, 1994, Cold Spring Harbor symposia on quantitative biology.

Platelet derived growth factor (PDGF), androgens and inflammation: possible etiologic factors in the development of prostatic hyperplasia.

J. Eble, C. Vlahos, W. Lamph, 1993, The Journal of urology.

Discovery and development of a novel class of nonsteroidal aromatase inhibitors

T. Lindstrom, N. Stamm, G. Sutton, 1987, Steroids.

Inhibition of central nervous system aromatase activity: a mechanism for fenarimol-induced infertility in the male rat.

N. MacLusky, J. Falcone, K. S. Hirsch, 1987, Toxicology and applied pharmacology.

Studies to elucidate the mechanism of fenarimol-induced infertility in male rats.

K. S. Hirsch, N. Owen, E. Adams, 1986, Toxicology and applied pharmacology.

LY207320 (6‐methylene‐4‐pregnene‐3,20‐dione) inhibits testosterone biosynthesis, androgen uptake, 5α‐reductase, and produces prostatic regression in male rats

N. Stamm, B. Neubauer, R. E. Toomey, 1993 .

LY191704: a selective, nonsteroidal inhibitor of human steroid 5 alpha-reductase type 1.

C. D. Jones, D. Russell, N. Stamm, 1993, Proceedings of the National Academy of Sciences of the United States of America.

LY191704 inhibits type I steroid 5 alpha-reductase in human scalp.

C. D. Jones, D. Tindall, B. Neubauer, 1996, The Journal of clinical endocrinology and metabolism.

Cancer cell dynamics in presence of telomerase inhibitors: analysis of in vitro data.

C. Harley, D. Dimitrov, I. Sidorov, 2002, Journal of theoretical biology.

Relationship of dietary zinc to 6-mercaptopurine teratogenesis and DNA metabolism in the rat.

L. Hurley, K. S. Hirsch, 1978, Teratology.

Searching for the Mechanism of Acetazolamide Teratogenesis

W. Scott, K. S. Hirsch, 1983 .

Acetazolamide teratology and its association with carbonic anhydrase inhibition in the mouse.

W. Scott, E. O'flaherty, K. S. Hirsch, 1983, Teratogenesis, carcinogenesis, and mutagenesis.

Comparative studies on acetazolamide teratogenesis in pregnant rats, rabbits, and rhesus monkeys.

W. Scott, J. DeSesso, K. S. Hirsch, 1981, Teratology.

Translocatable estrogen receptors in rat splenocytes.

B. H. Petersen, M. Myers, S. Queener, 1986, Life sciences.

Aromatase inhibition by 5-substituted pyrimidines and dihydropyrimidines.

C. D. Jones, K. S. Hirsch, J. Davenport, 1987, Journal of medicinal chemistry.

Synthesis of some 3, 4-dihydro-2h-1-benzothiopyran-4-ols

K. Berlin, K. S. Hirsch, V. L. Pruitt, 1990 .

LY 191704 : A selective , nonsteroidal inhibitor of human steroid 5 a-reductase type 1 ( 5 a-reductase / dihydrotestosterone / benzoquinolinone / benign prostatic hyperplasia )

C. D. Jones, D. Russell, N. Stamm, 2005 .

Embryonal Carcinoma Cells during Differentiation Binding of Insulin-like Growth Factors to Tera-2 Human Updated

G. Sledge, B. Roth, J. Fleck, 2006 .

Binding of insulin-like growth factors to Tera-2 human embryonal carcinoma cells during differentiation.

G. Sledge, B. Roth, J. Fleck, 1991, Cancer research.

Cancer treatment by telomerase inhibitors: predictions by a kinetic model.

C. Harley, D. Dimitrov, I. Sidorov, 2003, Mathematical biosciences.

Carbonic anhydrase distribution in rodent embryos and its relationship to acetazolamide teratogenesis.

W. Scott, C. Schreiner, K. S. Hirsch, 1981, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

Platelet‐derived growth factor induces proliferation of hyperplastic human prostatic stromal cells

Jeffrey A. Jones, J. Eble, C. Vlahos, 1993, Journal of cellular biochemistry.

Attenuating effect of zinc on abnormal placental morphology in 6-mercaptopurine treated rats.

L. Hurley, K. S. Hirsch, J. Levin, 1978, Teratology.

Endocrine effects of a new histamine H2-receptor antagonist, nizatidine (LY139037), in the male rat.

F. Tinsley, B. Neubauer, K. S. Hirsch, 1990, Toxicology and applied pharmacology.

Nonsteroidal inhibitors of human type I steroid 5-alpha-reductase.

A. Pike, N. Stamm, B. Neubauer, 1993, Journal of medicinal chemistry.

Estrogen synthetase inhibitors. 2. Comparison of the in vitro aromatase inhibitory activity for a variety of nitrogen heterocycles substituted with diarylmethane or diarylmethanol groups.

N. Stamm, M. Winter, K. S. Hirsch, 1990, Journal of medicinal chemistry.